Matthew P. Blischak - Net Worth and Insider Trading

Matthew P. Blischak Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Matthew P. Blischak owns 1 companies in total, including Finch Therapeutics Group Inc (FNCH) .

Click here to see the complete history of Matthew P. Blischak’s form 4 insider trades.

Insider Ownership Summary of Matthew P. Blischak

Ticker	Comapny	Transaction Date	Type of Owner
FNCH	Finch Therapeutics Group Inc	2023-05-16	Chief Executive Officer

Matthew P. Blischak Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Matthew P. Blischak Ownership Network

Ownership Network List of Matthew P. Blischak

No Data

Ownership Network Relation of Matthew P. Blischak

Matthew P. Blischak Owned Company Details

What does Finch Therapeutics Group Inc do?

Who are the key executives at Finch Therapeutics Group Inc?

Matthew P. Blischak is the Chief Executive Officer of Finch Therapeutics Group Inc. Other key executives at Finch Therapeutics Group Inc include Chief Financial Officer Lance E Thibault , Chief Business & Legal Officer Joseph Vittiglio , and Chief Operating Officer Marc Blaustein .

Finch Therapeutics Group Inc (FNCH) Insider Trades Summary

Over the past 18 months, Matthew P. Blischak made no insider transaction in Finch Therapeutics Group Inc (FNCH). Other recent insider transactions involving Finch Therapeutics Group Inc (FNCH) include a net sale of 9,712 shares made by Jeffery A Smisek , and a net purchase of 5,010 shares made by Susan E Graf .

In summary, during the past 3 months, insiders sold 8,242 shares of Finch Therapeutics Group Inc (FNCH) in total and bought 0 shares, with a net sale of 8,242 shares. During the past 18 months, 9,712 shares of Finch Therapeutics Group Inc (FNCH) were sold and 167 shares were bought by its insiders, resulting in a net sale of 9,545 shares.

Finch Therapeutics Group Inc (FNCH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Finch Therapeutics Group Inc Insider Transactions

No Available Data

Matthew P. Blischak Mailing Address

Above is the net worth, insider trading, and ownership report for Matthew P. Blischak. You might contact Matthew P. Blischak via mailing address: C/o Finch Therapeutics Group, Inc., 200 Inner Belt Road, Somerville Ma 02143.

Discussions on Matthew P. Blischak

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.